These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30269890)

  • 1. The Increasing Perioperative Impact of Natriuretic Peptides on Cardiovascular Outcomes.
    Stawiarski K; Mookadam F; Ramakrishna H
    J Cardiothorac Vasc Anesth; 2019 Jul; 33(7):2065-2069. PubMed ID: 30269890
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of natriuretic peptides in the differential diagnosis of dyspnea].
    Špác J
    Vnitr Lek; 2016; 62(7-8):640-5. PubMed ID: 27627091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis.
    Han ZJ; Wu XD; Cheng JJ; Zhao SD; Gao MZ; Huang HY; Gu B; Ma P; Chen Y; Wang JH; Yang CJ; Yan ZH
    PLoS One; 2015; 10(8):e0134376. PubMed ID: 26244664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectives.
    Clerico A; Passino C; Franzini M; Emdin M
    Future Cardiol; 2016 Sep; 12(5):573-84. PubMed ID: 27459871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in point-of-care testing for natriuretic peptides: potential impact on heart failure diagnosis and management.
    Iwaz JA; Maisel AS
    Expert Rev Mol Diagn; 2016 Jun; 16(6):641-50. PubMed ID: 26919295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of natriuretic peptides testing in heart failure - Impact of novel therapies.
    Mitoff P
    Clin Biochem; 2016 Jun; 49(9):643-644. PubMed ID: 27060498
    [No Abstract]   [Full Text] [Related]  

  • 7. [Natriuretic peptides in heart failure].
    Emdin M; Poletti R; Giannoni A; Mazzei MG; Mammini C; Gabutti A; Agazio A; Caprioli R; Passino C
    G Ital Nefrol; 2006; 23 Suppl 34():S32-7. PubMed ID: 16633992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Natriuretic peptides--new diagnostic markers in heart disease].
    Angermann CE; Ertl G
    Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Place of natriuretic peptides in the early diagnosis of heart failure in community medicine].
    Galinier M; Cariou E; Lairez O; Fournier P; Delmas C; Biendel-Picquet C; Roncalli J
    Presse Med; 2018 Sep; 47(9):804-810. PubMed ID: 30293850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of natriuretic peptides for acute heart failure: a review.
    Zhou SL; Zhang J; Song TT; Li X; Wang HX
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2415-2420. PubMed ID: 29762843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natriuretic peptides in heart failure and acute coronary syndrome.
    Gaggin HK; Januzzi JL
    Clin Lab Med; 2014 Mar; 34(1):43-58, vi. PubMed ID: 24507786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction.
    Gruson D; Lepoutre T; Ahn SA; Rousseau MF
    Int J Cardiol; 2014; 172(1):e250-2. PubMed ID: 24467978
    [No Abstract]   [Full Text] [Related]  

  • 13. A Test in Context: Critical Evaluation of Natriuretic Peptide Testing in Heart Failure.
    Francis GS; Felker GM; Tang WH
    J Am Coll Cardiol; 2016 Jan; 67(3):330-7. PubMed ID: 26796399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of midregional pro-adrenomedullin compared to natriuretic peptides for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort.
    Funke-Kaiser A; Havulinna AS; Zeller T; Appelbaum S; Jousilahti P; Vartiainen E; Blankenberg S; Sydow K; Salomaa V
    Ann Med; 2014 May; 46(3):155-62. PubMed ID: 24506434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Baseline Natriuretic Peptides and Atrial Fibrillation Recurrence After Catheter Ablation.
    Zhang Y; Chen A; Song L; Li M; Chen Y; He B
    Int Heart J; 2016; 57(2):183-9. PubMed ID: 26973277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic peptide and cardiovascular risk: is it about "U"?
    deFilippi CR; Seliger SL
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25999399
    [No Abstract]   [Full Text] [Related]  

  • 17. Natriuretic Peptides in Clinical Practice.
    Çavuşoğlu Y; Alper AT; Altay H; Çelik A; Demirkan B; Güvenç TS; Küçükoğlu MS; Nalbantgil S; Özdemir M; Özin B; Sayın T; Yıldırımtürk Ö; Yılmaz MB; Zorkun C
    Anatol J Cardiol; 2019 Mar; 21(Suppl 1):1-40. PubMed ID: 30860204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Will the therapy of chronic heart failure be guided by plasma levels of natriuretic peptides?].
    Hradec J; Krupicka J; Janota T
    Cas Lek Cesk; 2009; 148(8):383-8. PubMed ID: 19899725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic peptides revisited: new potentials and challenges in heart failure.
    Farmakis D; Parissis J; Papingiotis G; Lekakis J; Filippatos G
    J Cardiovasc Med (Hagerstown); 2016 Nov; 17(11):840-2. PubMed ID: 27680306
    [No Abstract]   [Full Text] [Related]  

  • 20. Natriuretic peptides in the diagnosis and management of acute heart failure.
    Mohammed AA; Januzzi JL
    Heart Fail Clin; 2009 Oct; 5(4):489-500. PubMed ID: 19631174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.